Softcell is a medical device company that has invented a revolutionary pH monitoring system, currently being developed to address the un-met clinical need for real time cellular pH monitoring.
Softcell’s patented technology can be applied to any soft tissue, to measure pH in circumstances where trauma or acute illness could be causing adverse effects. The pH monitoring system which comprises a monitor with single or multiple probes is currently undergoing development and approvals to convert the technology to a commercial system.
Trauma and other conditions can give rise to a serious complication called Acute Compartment Syndrome (ACS) that gradually cuts off the blood supply to the affected limb(s).
Trauma related ACS can be detected by measuring pressure and by clinical assessment. However, both pressure monitoring and clinical assessment are inaccurate diagnostic methods that can delay treatment, which may result in devastating disabilities, amputation or death. By comparison, pH monitoring can provide the earliest indication of potential tissue damage, allowing timely intervention to minimise the possible adverse outcomes.